108.35MMarket Cap
LossP/E TTM
Key Figures
1.320Open
1.320High
34.54KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.04%Turnover Ratio
1.300Prev. Close
1.280Low
29.91KTurnover
LossP/E Static
5.68P/B
0.00%Div Yield TTM
-69.63%ROA
1.92052wk High
0.31Volume Ratio
-23.49MNet Profit
84.65MShares
-0.4035EPS TTM
2.31Beta
-176.41%ROE
0.92352wk Low
3.08%Amplitude
--Gross Margin
108.35MMarket Cap
--Reward/Risk
4.37%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Vivani Medical Inc's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 118 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 4.62.In the medium term, the stock price is expected to remain stable.The company has shown average stock market performance over the past month, with weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Vivani Medical Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Vivani Medical Inc Highlights
StrengthsRisks
Vivani Medical Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Zimmer Biomet Holdings Inc
ZBH
31
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Vivani Medical Inc Info
Vivani Medical, Inc. is a clinical-stage biopharmaceutical company, developing miniature, ultra-long-acting drug implants. Leveraging its NanoPortal platform, it develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and to improve patient tolerance to their medication. Its lead program, NPM-115, is a six-month, subdermal, GLP-1 (exenatide) implant under development for chronic weight management in overweight individuals. Its pipeline includes NPM-139 (semaglutide implant), which is also under development for chronic weight management. NPM-119 refers to its six-month, subdermal, GLP-1 (exenatide) implant under development for the treatment of type 2 diabetes. These NanoPortal implants are designed to provide patients with the opportunity to realize the benefit of their medication by avoiding the challenges associated with the daily or weekly administration of orals and injectables.
Ticker SymbolVANI
CompanyVivani Medical Inc
CEOMendelsohn (Adam)
Websitehttps://vivani.com/
Shareholders
FAQs
What is the current price of Vivani Medical Inc (VANI)?
The current price of Vivani Medical Inc (VANI) is 1.28.
What is the symbol of Vivani Medical Inc?
The ticker symbol of Vivani Medical Inc is VANI.
What is the 52-week high of Vivani Medical Inc?
The 52-week high of Vivani Medical Inc is 1.92.
What is the 52-week low of Vivani Medical Inc?
The 52-week low of Vivani Medical Inc is 0.92.
What is the market capitalization of Vivani Medical Inc?
The market capitalization of Vivani Medical Inc is 108.35M.
Is Vivani Medical Inc (VANI) currently rated as Buy, Hold, or Sell?
According to analysts, Vivani Medical Inc (VANI) has an overall rating of Buy, with a price target of 4.62.
What is the Earnings Per Share (EPS TTM) of Vivani Medical Inc (VANI)?
The Earnings Per Share (EPS TTM) of Vivani Medical Inc (VANI) is -0.43.
